CHE vs. DORM

Last updated Aug 4, 2026

CHE (Chemed Corporation) and DORM (Dorman Products, Inc.) are both stocks. CHE operates in Medical Care Facilities (Healthcare), while DORM operates in Auto Parts (Consumer Cyclical). Over the past 10 years, CHE returned 14.54%/yr vs 7.21%/yr for DORM. Their 0.20 correlation means their historical movements had little consistent relationship.

Performance

CHE vs. DORM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Chemed Corporation (CHE) and Dorman Products, Inc. (DORM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CHE achieves a 26.68% return, which is significantly higher than DORM's 3.64% return. Over the past 10 years, CHE has outperformed DORM with an annualized return of 14.54%, while DORM has yielded a comparatively lower 7.21% annualized return.

CHE

• 1D: 1.56%
• 1M: 10.40%
• 6M: 24.52%
• YTD: 26.68%
• 1Y: 30.07%
• 3Y*: 2.09%
• 5Y*: 3.04%
• 10Y*: 14.54%
• ALL TIME*: 9.98%

DORM

• 1D: -4.12%
• 1M: -7.24%
• 6M: 0.86%
• YTD: 3.64%
• 1Y: 7.18%
• 3Y*: 12.64%
• 5Y*: 5.47%
• 10Y*: 7.21%
• ALL TIME*: 12.70%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
CHE Chemed Corporation	$100.12M	$85.69M	$92.33M
DORM Dorman Products, Inc.	$41.04M	$36.52M	$37.36M

CHE vs. DORM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CHE Chemed Corporation	26.68%	-18.87%	-9.11%	14.90%	-3.22%	-0.38%	21.59%	55.58%	17.01%	52.32%
DORM Dorman Products, Inc.	3.64%	-4.91%	55.32%	3.14%	-28.44%	30.17%	14.66%	-15.89%	47.24%	-16.32%

Correlation

The correlation between CHE and DORM is 0.23, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.23
Correlation (3Y) Balances recent behavior with more history.	0.29
Correlation (5Y) Shows whether the relationship held over a longer period.	0.31
Correlation (10Y) Provides a long-term view across more market conditions.	0.29
Correlation (All Time) Calculated using the full available price history since Mar 12, 1991	0.20

The correlation between CHE and DORM shifts across timeframes, from 0.20 (all time) to 0.31 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CHE : $7.18B DORM : $3.82B
EPS CHE : $19.77 DORM : $6.21
PE Ratio CHE : 27.34 DORM : 20.57
PEG Ratio CHE : 12.87 DORM : 1.43
PS Ratio CHE : 2.90 DORM : 1.82
PB Ratio CHE : 8.74 DORM : 2.65
Total Revenue (TTM) CHE : $2.60B DORM : $2.15B
Gross Profit (TTM) CHE : $386.66M DORM : $874.92M
EBITDA (TTM) CHE : $401.94M DORM : $323.26M

Return for Risk

CHE vs. DORM — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CHE

CHE Risk / Return Rank: 73
CHE Sharpe Ratio Rank: 76
CHE Sortino Ratio Rank: 69
CHE Omega Ratio Rank: 75
CHE Calmar Ratio Rank: 71
CHE Martin Ratio Rank: 72

DORM

DORM Risk / Return Rank: 48
DORM Sharpe Ratio Rank: 52
DORM Sortino Ratio Rank: 47
DORM Omega Ratio Rank: 46
DORM Calmar Ratio Rank: 48
DORM Martin Ratio Rank: 48

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CHE vs. DORM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Chemed Corporation (CHE) and Dorman Products, Inc. (DORM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CHE	DORM	Difference
Sharpe ratio: Return per unit of total volatility	1.03	0.20	+0.83
Sortino ratio: Return per unit of downside risk	1.45	0.55	+0.90
Omega ratio: Gain probability vs. loss probability	1.23	1.07	+0.16
Calmar ratio: Return relative to maximum drawdown	1.31	0.18	+1.13
Martin ratio: Return relative to average drawdown	3.21	0.31	+2.90

CHE vs. DORM - Sharpe Ratio Comparison

The current CHE Sharpe Ratio is 1.03, which is higher than the DORM Sharpe Ratio of 0.20. The chart below compares the historical Sharpe Ratios of CHE and DORM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CHE vs. DORM - Drawdown Comparison

The maximum CHE drawdown since its inception was -83.78%, smaller than the maximum DORM drawdown of -88.99%. Use the drawdown chart below to compare losses from any high point for CHE and DORM.

Drawdown Indicators

	CHE	DORM	Difference
Max Drawdown Largest peak-to-trough decline	-83.78%	-88.99%	+5.21%
Max Drawdown (1Y) Largest decline over 1 year	-22.98%	-39.58%	+16.60%
Max Drawdown (3Y) Largest decline over 3 years	-42.88%	-39.58%	-3.30%
Max Drawdown (5Y) Largest decline over 5 years	-42.88%	-49.32%	+6.44%
Max Drawdown (10Y) Largest decline over 10 years	-42.88%	-50.78%	+7.90%
Current Drawdown Current decline from peak	-16.12%	-23.24%	+7.12%
Average Drawdown Average peak-to-trough decline	-16.48%	-23.72%	+7.24%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.39%	23.35%	-13.96%

Volatility

CHE vs. DORM - Volatility Comparison

The current volatility for Chemed Corporation (CHE) is 6.68%, while Dorman Products, Inc. (DORM) has a volatility of 12.01%. This indicates that CHE experiences smaller price fluctuations and is considered to be less risky than DORM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CHE	DORM	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.68%	12.01%	-5.33%
Volatility (6M) Calculated over the trailing 6-month period	24.94%	25.27%	-0.33%
Volatility (1Y) Calculated over the trailing 1-year period	29.24%	36.04%	-6.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.35%	32.90%	-7.55%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.95%	33.39%	-7.44%

Dividends

CHE vs. DORM - Dividend Comparison

CHE's dividend yield for the trailing twelve months is around 0.44%, while DORM has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CHE Chemed Corporation	0.44%	0.51%	0.34%	0.27%	0.29%	0.26%	0.25%	0.28%	0.41%	0.44%	0.62%	0.61%
DORM Dorman Products, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

CHE vs. DORM - Profitability Comparison

The chart below illustrates the profitability comparison between Chemed Corporation and Dorman Products, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CHE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Chemed Corporation reported a gross profit of -198.89M and revenue of 673.25M. Therefore, the gross margin over that period was -29.5%.

DORM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Dorman Products, Inc. reported a gross profit of 190.16M and revenue of 528.77M. Therefore, the gross margin over that period was 36.0%.

CHE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Chemed Corporation reported an operating income of 89.20M and revenue of 673.25M, resulting in an operating margin of 13.3%.

DORM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Dorman Products, Inc. reported an operating income of 58.78M and revenue of 528.77M, resulting in an operating margin of 11.1%.

CHE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Chemed Corporation reported a net income of 67.70M and revenue of 673.25M, resulting in a net margin of 10.1%.

DORM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Dorman Products, Inc. reported a net income of 43.55M and revenue of 528.77M, resulting in a net margin of 8.2%.

Frequently Asked Questions

Can I hold both CHE and DORM in my portfolio?

CHE and DORM have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CHE or DORM?

DORM has higher volatility (12.01%) compared to CHE (6.68%). In terms of maximum drawdown, CHE dropped -83.78% vs DORM's -88.99%.

Which has better risk-adjusted returns?

CHE currently has the higher Sharpe Ratio (1.03 vs 0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.